UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival

Annals of oncology, 2021-08, Vol.32 (8), p.1015-1024

2021

Volltextzugriff (PDF)

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

Breast cancer research : BCR, 2023-08, Vol.25 (1), p.1-103, Article 103

2023

Volltextzugriff (PDF)

Ageism and caring attitudes among nurses in oncology

International psychogeriatrics, 2016-05, Vol.28 (5), p.749-757

2016

Volltextzugriff (PDF)

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

European heart journal cardiovascular imaging, 2014-10, Vol.15 (10), p.1063-1093

2014

Volltextzugriff (PDF)

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium

Annals of oncology, 2018-09, Vol.29 (9), p.1987-1994

2018

Volltextzugriff (PDF)

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

Breast cancer research and treatment, 2018-04, Vol.168 (2), p.357-364

2018

Volltextzugriff (PDF)

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

Annals of oncology, 2021-10, Vol.32 (10), p.1256-1266

2021

Volltextzugriff (PDF)

Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in post-treatment cancer patients

Quality of life research, 2021-02, Vol.30 (2), p.425-436

2021

Volltextzugriff (PDF)

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study

Annals of oncology, 2015-02, Vol.26 (2), p.325-332

2015

Volltextzugriff (PDF)

Recurrent or primary metastatic cervical cancer: current and future treatments

ESMO open, 2022-10, Vol.7 (5), p.100579, Article 100579

2022

Volltextzugriff (PDF)

Communication of healthcare professionals: Is there ageism?

European journal of cancer care, 2018-01, Vol.27 (1), p.e12780-n/a

2018

Volltextzugriff (PDF)

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery

Quality of life research, 2019-03, Vol.28 (3), p.663-676

2019

Volltextzugriff (PDF)

Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome

Annals of oncology, 2019-05, Vol.30, p.iii18-iii18

2019

Volltextzugriff (PDF)

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Annals of oncology, 2018-03, Vol.29 (3), p.661-668

2018

Volltextzugriff (PDF)

EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology

European heart journal cardiovascular imaging, 2015-05, Vol.16 (5), p.466-470

2015

Volltextzugriff (PDF)

Ribociclib (RIB) + fulvestrant (FUL) for advanced breast cancer (ABC): Progression-free survival (PFS) subgroup and tumor response analyses from MONALEESA-3

Annals of oncology, 2018-10, Vol.29, p.viii107-viii107

2018

Volltextzugriff (PDF)

Ribociclib (RIB) + fulvestrant (FUL) in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-3 biomarker analyses

Annals of oncology, 2018-10, Vol.29, p.viii113-viii114

2018

Volltextzugriff (PDF)

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Annals of oncology, 2010-03, Vol.21 (3), p.474-480

2010

Volltextzugriff (PDF)

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

Clinical & translational oncology, 2020-10, Vol.22 (10), p.1857-1866

2020

Volltextzugriff (PDF)

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

ESMO open, 2023-02, Vol.8 (1), p.100772, Article 100772

2023

Volltextzugriff (PDF)

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

Annals of oncology, 2003-01, Vol.14 (1), p.123-130

2003

Volltextzugriff (PDF)

1880 Systematic review regarding the impact of chemotherapy on symptoms and health related quality-of-life in patients with advanced breast cancer

European journal of cancer (1990), 2015-09, Vol.51, p.S293-S293

2015

Volltextzugriff (PDF)

European inter-institutional impact study of MammaPrint

Breast (Edinburgh), 2014-08, Vol.23 (4), p.423-428

2014

Volltextzugriff (PDF)

1 – 25 von 561

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(488)
Mit Volltextzugriff
(413)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(254)
Life Sciences & Biomedicine
(161)
Humans
(144)
Female
(99)
Physical Sciences
(78)
Biological And Medical Sciences
(71)
Human Health Sciences
(67)
Sciences De La Santé Humaine
(67)
Oncology
(65)
Physics
(49)
Middle Aged
(47)
Animals
(46)
Oncologie
(45)
Chemistry
(44)
Fundamental And Applied Biological Sciences. Psychology
(44)
Adult
(43)
Male
(43)
Aged
(42)
Breast Neoplasms - Drug Therapy
(30)
Medical Sciences
(27)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival

Updated overall survival from the MONALEESA-3 trial in postmenopausal women with HR+/HER2− advanced breast cancer receiving first-line ribociclib plus fulvestrant

Ageism and caring attitudes among nurses in oncology

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET)

Adherence to geriatric assessment-based recommendations in older patients with cancer: a multicenter prospective cohort study in Belgium

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

Continuous versus intermittent extended adjuvant letrozole for breast cancer: final results of randomized phase III SOLE (Study of Letrozole Extension) and SOLE Estrogen Substudy

Randomized controlled trial of a group intervention combining self-hypnosis and self-care: secondary results on self-esteem, emotional distress and regulation, and mindfulness in post-treatment cancer patients

Neoadjuvant treatment with docetaxel plus lapatinib, trastuzumab, or both followed by an anthracycline-based chemotherapy in HER2-positive breast cancer: results of the randomised phase II EORTC 10054 study

Recurrent or primary metastatic cervical cancer: current and future treatments

Communication of healthcare professionals: Is there ageism?

Determining clinically important differences in health-related quality of life in older patients with cancer undergoing chemotherapy or surgery

Tryptophan catabolism differentiates breast cancer patients from healthy controls but does not predict outcome

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

EACVI/HFA Cardiac Oncology Toxicity Registry in breast cancer patients: rationale, study design, and methodology (EACVI/HFA COT Registry)--EURObservational Research Program of the European Society of Cardiology

Ribociclib (RIB) + fulvestrant (FUL) for advanced breast cancer (ABC): Progression-free survival (PFS) subgroup and tumor response analyses from MONALEESA-3

Ribociclib (RIB) + fulvestrant (FUL) in hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC): MONALEESA-3 biomarker analyses

An open-label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population

Cardiac safety of dual anti-HER2 blockade with pertuzumab plus trastuzumab in early HER2-positive breast cancer in the APHINITY trial

Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin’s disease

1880 Systematic review regarding the impact of chemotherapy on symptoms and health related quality-of-life in patients with advanced breast cancer

European inter-institutional impact study of MammaPrint

Suchergebnisse filtern